Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide.
These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.
This report elaborates on the current development of the Conjugate Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sun Pharmaceutical Industries Ltd
Pfenex Inc
Mitsubishi Tanabe Pharma Corp
GlaxoSmithKline Plc
Integrated Biotherapeutics Inc
Aurobindo Pharma Ltd
Pfizer Inc
Merck & Co Inc
Sanofi
Serum Institute of India Pvt Ltd
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Multivalent Conjugate Vaccines
Monovalent Conjugate Vaccines
Application:
Baby
Adult
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Conjugate Vaccines Industry Overview
-
1.1.1 Conjugate Vaccines Market Scope and Market Segments
-
1.1.2 Conjugate Vaccines Industry Characteristics
-
1.1.3 Global and China Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Conjugate Vaccines Production Value and Growth Rate (2017-2028)
-
1.2 Global Conjugate Vaccines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Multivalent Conjugate Vaccines
-
1.2.2 Monovalent Conjugate Vaccines
-
1.3 Global Conjugate Vaccines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Baby
-
1.3.2 Adult
-
1.4 Market Analysis by Region
-
1.4.1 North America Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Conjugate Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Conjugate Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Conjugate Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Conjugate Vaccines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Conjugate Vaccines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Conjugate Vaccines Industry Porter's Five Forces Model Analysis
-
2.2.3 Conjugate Vaccines Industry PEST Analysis
-
2.3 Conjugate Vaccines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Conjugate Vaccines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Conjugate Vaccines Industry
Chapter 3 Global and China Conjugate Vaccines Market, by Manufacturer
-
3.1 Global and China Conjugate Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Conjugate Vaccines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Conjugate Vaccines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Conjugate Vaccines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Conjugate Vaccines Market Top 3 Players
Chapter 4 Global and China Conjugate Vaccines Market, by Type (2017-2028)
-
4.1 Conjugate Vaccines Market Trend, by Type
-
4.2 Global Conjugate Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Conjugate Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Conjugate Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Conjugate Vaccines Price Trend, by Type (2017-2028)
-
4.3 China Conjugate Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Conjugate Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Conjugate Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Conjugate Vaccines Price Trend, by Type (2017-2028)
Chapter 5 Global and China Conjugate Vaccines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Conjugate Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Conjugate Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Conjugate Vaccines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Conjugate Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Conjugate Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Conjugate Vaccines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Conjugate Vaccines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Conjugate Vaccines Market Analysis
-
7.1 North America Conjugate Vaccines Market, by Type
-
7.2 North America Conjugate Vaccines Market, by Application
-
7.3 North America Conjugate Vaccines Market Analysis and Forecast, by Country
-
7.3.1 United States Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Conjugate Vaccines Market Analysis
-
8.1 Europe Conjugate Vaccines Market, by Type
-
8.2 Europe Conjugate Vaccines Market, by Application
-
8.3 Europe Conjugate Vaccines Market Analysis and Forecast, by Country
-
8.3.1 Germany Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Conjugate Vaccines Market Analysis
-
9.1 APAC Conjugate Vaccines Market, by Type
-
9.2 APAC Conjugate Vaccines Market, by Application
-
9.3 APAC Conjugate Vaccines Market Analysis and Forecast, by Country
-
9.3.1 China Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Conjugate Vaccines Market Analysis
-
10.1 Latin America, Middle East and Africa Conjugate Vaccines Market, by Type
-
10.2 Latin America, Middle East and Africa Conjugate Vaccines Market, by Application
-
10.3 Latin America, Middle East and Africa Conjugate Vaccines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Conjugate Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Conjugate Vaccines Company Profiles
-
11.1 Sun Pharmaceutical Industries Ltd
-
11.1.1 Sun Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sun Pharmaceutical Industries Ltd Conjugate Vaccines Product Profiles, Application and Specification
-
11.1.3 Sun Pharmaceutical Industries Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Pfenex Inc
-
11.2.1 Pfenex Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Pfenex Inc Conjugate Vaccines Product Profiles, Application and Specification
-
11.2.3 Pfenex Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Mitsubishi Tanabe Pharma Corp
-
11.3.1 Mitsubishi Tanabe Pharma Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Product Profiles, Application and Specification
-
11.3.3 Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 GlaxoSmithKline Plc
-
11.4.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 GlaxoSmithKline Plc Conjugate Vaccines Product Profiles, Application and Specification
-
11.4.3 GlaxoSmithKline Plc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Integrated Biotherapeutics Inc
-
11.5.1 Integrated Biotherapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Integrated Biotherapeutics Inc Conjugate Vaccines Product Profiles, Application and Specification
-
11.5.3 Integrated Biotherapeutics Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Aurobindo Pharma Ltd
-
11.6.1 Aurobindo Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Aurobindo Pharma Ltd Conjugate Vaccines Product Profiles, Application and Specification
-
11.6.3 Aurobindo Pharma Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Pfizer Inc
-
11.7.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Pfizer Inc Conjugate Vaccines Product Profiles, Application and Specification
-
11.7.3 Pfizer Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Merck & Co Inc
-
11.8.1 Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Merck & Co Inc Conjugate Vaccines Product Profiles, Application and Specification
-
11.8.3 Merck & Co Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Sanofi
-
11.9.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Sanofi Conjugate Vaccines Product Profiles, Application and Specification
-
11.9.3 Sanofi Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Serum Institute of India Pvt Ltd
-
11.10.1 Serum Institute of India Pvt Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Serum Institute of India Pvt Ltd Conjugate Vaccines Product Profiles, Application and Specification
-
11.10.3 Serum Institute of India Pvt Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Conjugate Vaccines Industry Investment Prospect and Risk Assessment
-
12.1 Conjugate Vaccines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Conjugate Vaccines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Global Conjugate Vaccines Production Value and Growth Rate (2017-2028)
-
Figure China Conjugate Vaccines Production Value and Growth Rate (2017-2028)
-
Figure Global Conjugate Vaccines Market Size and Growth Rate of Multivalent Conjugate Vaccines (2017-2028)
-
Figure Global Conjugate Vaccines Market Size and Growth Rate of Monovalent Conjugate Vaccines (2017-2028)
-
Figure Global Conjugate Vaccines Market Size and Growth Rate of Baby (2017-2028)
-
Figure Global Conjugate Vaccines Market Size and Growth Rate of Adult (2017-2028)
-
Figure North America Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Conjugate Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Conjugate Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Conjugate Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Conjugate Vaccines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Conjugate Vaccines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Conjugate Vaccines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Conjugate Vaccines Market Share, by Manufacturer in 2021
-
Figure Global and China Conjugate Vaccines Market Share, by Manufacturer in 2022
-
Table Global Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table Global Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Global Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Global Conjugate Vaccines Sales Value, by Type (2017-2028)
-
Table Global Conjugate Vaccines Sales Value Share, by Type (2017-2028)
-
Figure Global Conjugate Vaccines Price Trend, by Type (2017-2028)
-
Table China Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table China Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure China Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table China Conjugate Vaccines Sales Value, by Type (2017-2028)
-
Table China Conjugate Vaccines Sales Value Share, by Type (2017-2028)
-
Figure China Conjugate Vaccines Price Trend, by Type (2017-2028)
-
Table Global Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table Global Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Global Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Table Global Conjugate Vaccines Sales Value, by Application (2017-2028)
-
Table Global Conjugate Vaccines Sales Value Share, by Application (2017-2028)
-
Figure Global Conjugate Vaccines Sales Value Share, by Application (2017-2028)
-
Table China Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table China Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Table China Conjugate Vaccines Sales Value, by Application (2017-2028)
-
Table China Conjugate Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China Conjugate Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure North America Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Conjugate Vaccines Production, Import, Consumption and Export (2017-2022)
-
Table North America Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table North America Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure North America Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table North America Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table North America Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure North America Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure United States Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure United States Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Canada Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Europe Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table Europe Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Europe Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Europe Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table Europe Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Europe Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Germany Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure UK Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure UK Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure France Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure France Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Italy Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Spain Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Poland Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Russia Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Table APAC Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table APAC Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure APAC Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table APAC Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table APAC Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure APAC Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Japan Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure India Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure India Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Conjugate Vaccines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Conjugate Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Conjugate Vaccines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Conjugate Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Conjugate Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Conjugate Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Sun Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sun Pharmaceutical Industries Ltd Product Profiles, Application and Specification
-
Table Sun Pharmaceutical Industries Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfenex Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfenex Inc Product Profiles, Application and Specification
-
Table Pfenex Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mitsubishi Tanabe Pharma Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mitsubishi Tanabe Pharma Corp Product Profiles, Application and Specification
-
Table Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Plc Product Profiles, Application and Specification
-
Table GlaxoSmithKline Plc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Integrated Biotherapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Integrated Biotherapeutics Inc Product Profiles, Application and Specification
-
Table Integrated Biotherapeutics Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Aurobindo Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Aurobindo Pharma Ltd Product Profiles, Application and Specification
-
Table Aurobindo Pharma Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Inc Product Profiles, Application and Specification
-
Table Pfizer Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck & Co Inc Product Profiles, Application and Specification
-
Table Merck & Co Inc Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Serum Institute of India Pvt Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Serum Institute of India Pvt Ltd Product Profiles, Application and Specification
-
Table Serum Institute of India Pvt Ltd Conjugate Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
